Fig. 1.
![Fig. 1. Scattergram showing the difference (P < .0001) in 8-epi-PGF2α values in SLE patients and controls and the higher 8-epi-PGF2α values (P < .001) in aPL positive [aPL (+)] patients than in negative [aPL (−)] ones.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/90/10/10.1182_blood.v90.10.3931/3/bl_0031f1.jpeg?Expires=1724871693&Signature=P6sQJMA4q~29pY4JZ3CZEtWWVZ9GOpPQyGvRKHmOUMAGn5wlcj-64HaWx0QeEV~R7DFZ77axWrB876mzLYygj9N~OiAlXOTdg75QKVUdPU9h4UPfiYfb-5Msjx2kPmXGtbl7FgtFLUcJtBklKTFppU5McTnoRUkelR92yuHgKuISw8o6efUY1koNZkMH1WdIx3EbLxAy7M5qQJpYAyVrW6kn-2UU88eaH3R4JF6yxOpfO4vkejqVnBZ7waVSLPuIHOJ7AdrY3yIZP9XpDiPuixZEsd~MzY6eJa92OzLw5tnMR4EBlTBbrM1AbT-UjA-BCY--rh1uv9BqV6bk9FVWqA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Scattergram showing the difference (P < .0001) in 8-epi-PGF2α values in SLE patients and controls and the higher 8-epi-PGF2α values (P < .001) in aPL positive [aPL (+)] patients than in negative [aPL (−)] ones.
Scattergram showing the difference (P < .0001) in 8-epi-PGF2α values in SLE patients and controls and the higher 8-epi-PGF2α values (P < .001) in aPL positive [aPL (+)] patients than in negative [aPL (−)] ones.
